How non-THC cannabinoids like CBD might fight cancer

Preclinical evidence suggests non-THC cannabinoids, particularly CBD, can inhibit cancer cell growth through multiple mechanisms including receptor modulation and redox changes, plus offer anti-inflammatory effects relevant to the tumor environment.

Afrin, Farjana et al.·Cancers·2020·Moderate EvidenceReview
RTHC-02372ReviewModerate Evidence2020RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Review
Evidence
Moderate Evidence
Sample
Not reported

What This Study Found

THC can inhibit cancer cell growth via CB1R and CB2R modulation, but clinical confirmation is lacking. Non-THC cannabinoids like CBD work through different mechanisms: non-CB1R/CB2R G-protein-coupled receptors, neurotransmitter receptors, and transcription factors that modulate oncogenic signaling and redox homeostasis. Cannabinoids also have anti-inflammatory properties relevant to peritumoural edema and the tumor immune microenvironment.

Key Numbers

No specific clinical data. Review covered preclinical evidence across multiple cancer types and cannabinoid compounds.

How They Did This

Review documenting emerging mechanisms of anti-cancer actions of non-THC cannabinoids, covering preclinical evidence from cell and animal studies.

Why This Research Matters

Low-THC cannabis and CBD products are widely available without the psychoactive effects of THC. Understanding their anti-cancer mechanisms could inform future treatment development without the barriers associated with THC.

The Bigger Picture

The shift toward non-THC cannabinoids for cancer research sidesteps the psychoactive and regulatory challenges of THC while potentially offering therapeutic benefits through distinct mechanisms.

What This Study Doesn't Tell Us

Entirely preclinical evidence. No human clinical trials confirm anti-cancer effects. In vitro results often do not translate to clinical benefit. Doses used in lab studies may not be achievable in humans.

Questions This Raises

  • ?Will any non-THC cannabinoid advance to clinical cancer trials?
  • ?Could CBD be combined with standard chemotherapy for additive effects?

Trust & Context

Key Stat:
Multiple anti-cancer mechanisms identified for CBD
Evidence Grade:
Comprehensive review of preclinical evidence, but no human clinical data for anti-cancer effects.
Study Age:
2020 review.
Original Title:
Can Hemp Help? Low-THC Cannabis and Non-THC Cannabinoids for the Treatment of Cancer.
Published In:
Cancers, 12(4) (2020)
Database ID:
RTHC-02372

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study

Summarizes existing research on a topic.

What do these levels mean? →

Frequently Asked Questions

Can CBD treat cancer?

Preclinical studies show CBD and other non-THC cannabinoids can inhibit cancer cell growth through multiple mechanisms, but no human clinical trials have confirmed these effects in actual patients.

How might non-THC cannabinoids fight cancer?

They appear to work through receptors and pathways different from THC, including modulation of oncogenic signaling, redox balance, and inflammation in the tumor environment.

Read More on RethinkTHC

Cite This Study

RTHC-02372·https://rethinkthc.com/research/RTHC-02372

APA

Afrin, Farjana; Chi, Mengna; Eamens, Andrew L; Duchatel, Ryan J; Douglas, Alicia M; Schneider, Jennifer; Gedye, Craig; Woldu, Ameha S; Dun, Matthew D. (2020). Can Hemp Help? Low-THC Cannabis and Non-THC Cannabinoids for the Treatment of Cancer.. Cancers, 12(4). https://doi.org/10.3390/cancers12041033

MLA

Afrin, Farjana, et al. "Can Hemp Help? Low-THC Cannabis and Non-THC Cannabinoids for the Treatment of Cancer.." Cancers, 2020. https://doi.org/10.3390/cancers12041033

RethinkTHC

RethinkTHC Research Database. "Can Hemp Help? Low-THC Cannabis and Non-THC Cannabinoids for..." RTHC-02372. Retrieved from https://rethinkthc.com/research/afrin-2020-can-hemp-help-lowthc

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.